The proposed biosimilar to Keytruda demonstrated pharmacokinetic bioequivalence in a multicountry Phase 1 study involving non-small cell lung cancer patients
The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty
The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms
The company also announced a major portfolio shift, planning to divest its Immunodiagnostics business in China, a unit that generated approximately 6% of its fiscal 2025 revenue
The private funding rose 38% amid growing international collaborations and CDMO demand
New pediatric nebulizer combines playful design and engaging features to make breathing treatments less stressful for children and parents
Leadership transition strengthens Redcliffe Labs’ focus on scaling technology-led diagnostics, operational excellence, and preventive healthcare access
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders
Discussions focused on digital health, non-communicable diseases, resilient supply chains, medical innovation, and healthcare workforce development
Subscribe To Our Newsletter & Stay Updated
